Mounjaro Alternatives 2026: Affordable Tirzepatide Options
Find the most affordable Mounjaro alternatives in 2026. Compounded tirzepatide starting at $125/month delivers the same dual-action GLP-1 medication at up to 90% less.
Written by Trimi Medical Team. Medically reviewed by Dr. Asad Niazi, MD, MPH. This guide evaluates the most affordable and effective Mounjaro alternatives available in 2026.
Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.
More on GLP-1 Provider Comparisons
Mounjaro vs Compounded Tirzepatide
Detailed comparison of Mounjaro and compounded tirzepatide.
Mounjaro Cost 2026
Complete Mounjaro pricing breakdown for 2026.
Cheapest Tirzepatide 2026
Every tirzepatide option ranked by price.
How to Get Tirzepatide Cheap
Step-by-step guide to affordable tirzepatide access.
Why Patients Need Mounjaro Alternatives
Mounjaro (tirzepatide) has been a breakthrough in weight management, offering the most potent weight loss results of any approved medication through its unique dual GIP/GLP-1 receptor mechanism. The SURMOUNT clinical trials produced average weight loss of 20 to 22.5 percent at the highest dose — results that rival what some patients achieve with bariatric surgery, but without the surgical risks and recovery.
Despite these impressive results, Mounjaro's retail price of $1,000 to $1,200 per month puts it beyond the reach of most patients paying out of pocket. Insurance coverage for weight loss use is inconsistent and often denied, particularly since Mounjaro's FDA approval is for type 2 diabetes, not obesity. The ongoing supply challenges add another barrier, leaving many patients unable to access the medication even when they can afford it.
These barriers have created enormous demand for affordable alternatives that deliver the same clinical benefits. The most compelling option is compounded tirzepatide, which contains the identical active ingredient at 75 to 90 percent less cost than brand-name Mounjaro.
Top Mounjaro Alternatives Ranked
1. Compounded Tirzepatide (Best Overall)
Compounded tirzepatide is the most direct Mounjaro alternative — same active molecule, same dual receptor mechanism, same expected clinical outcomes. The primary advantage is price: starting at approximately $125 per month through Trimi, compounded tirzepatide saves patients approximately $10,000 per year compared to brand-name Mounjaro. The medication is prescribed by licensed providers, prepared by accredited compounding pharmacies, and delivered directly to patients' doors.
2. Compounded Semaglutide (Strong Alternative)
For patients who want a GLP-1 medication at the lowest possible cost, compounded semaglutide starts at $149 per month through Trimi. While semaglutide is a single-target GLP-1 agonist (compared to tirzepatide's dual action), it still produces significant weight loss averaging 15 to 17 percent of body weight. Some patients actually prefer semaglutide due to its longer track record and slightly different side effect profile.
3. Zepbound (Brand-Name, If Insured)
Zepbound is Eli Lilly's tirzepatide product specifically FDA-approved for weight management. For patients with insurance that covers anti-obesity medications, Zepbound may be accessible at a reasonable copay. However, retail pricing of approximately $1,060 per month makes it only marginally less expensive than Mounjaro for out-of-pocket patients.
4. Mounjaro Savings Card
Eli Lilly's savings card can reduce Mounjaro copays for commercially insured patients, potentially bringing monthly costs to $25 or less. However, the card requires insurance coverage, has maximum benefit caps, and is not available to Medicare, Medicaid, or uninsured patients. See our savings card comparison for full details.
Complete Cost Comparison
| Option | Monthly Cost | Annual Cost | Annual Savings vs Mounjaro |
|---|---|---|---|
| Mounjaro (Brand) | $1,050/mo | $12,600/yr | — |
| Zepbound (Brand) | $1,060/mo | $12,720/yr | ~$0 (similar) |
| Compounded Tirzepatide | $125 - $250/mo | $1,500 - $3,000/yr | $9,600 - $11,100 |
| Compounded Semaglutide | $99 - $199/mo | $1,188 - $2,388/yr | $10,200 - $11,400 |
Quality Considerations for Compounded Alternatives
The quality of compounded tirzepatide is the most important factor when choosing an alternative to brand-name Mounjaro. Not all compounding pharmacies maintain the same standards, so selecting a provider with verified quality practices is essential.
PCAB accreditation or FDA 503A registration ensures rigorous quality oversight
Third-party potency testing confirms active ingredient concentration in each batch
Sterility testing meets USP 797 standards for injectable medications
Licensed providers conduct thorough medical evaluations before prescribing
Cold-chain shipping maintains medication integrity during delivery
Transparent pharmacy identification allows patients to verify credentials
Trimi meets all of these quality standards. Our quality verification guide provides additional detail on how to evaluate any compounded medication provider.
How to Get Started with a Mounjaro Alternative
Accessing compounded tirzepatide through Trimi is straightforward. Complete the online health assessment, which covers your medical history, current medications, weight loss goals, and any relevant health conditions. A board-certified provider reviews your information — typically within 24 hours — and prescribes compounded tirzepatide at the appropriate starting dose.
Your medication is compounded by an accredited pharmacy and shipped to your door, usually within 5 to 7 days. The package includes the medication vial, syringes, alcohol swabs, and detailed injection instructions. Ongoing care includes regular provider check-ins, dose adjustments, side effect management, and comprehensive support for first-time patients.
Bottom Line
Mounjaro's clinical results are extraordinary, but its price is not sustainable for most patients. Compounded tirzepatide delivers the same dual-action active ingredient at 75 to 90 percent less cost, making it the most practical alternative for patients who need long-term treatment to achieve and maintain significant weight loss.
Through Trimi, compounded tirzepatide starts at $125 per month with transparent pricing, accredited pharmacy partnerships, and specialized medical support. The savings of $10,000 or more per year versus brand-name Mounjaro mean that more patients can access this life-changing medication for as long as they need it.
Frequently Asked Questions
What is the cheapest alternative to Mounjaro in 2026?
The most affordable Mounjaro alternative in 2026 is compounded tirzepatide, available through telehealth providers starting at approximately $125 per month. This compounded version contains the same active ingredient — tirzepatide — that makes Mounjaro effective. Through Trimi, compounded tirzepatide includes the medication, provider consultations, medical oversight, and shipping in one transparent monthly price with no long-term contracts.
Is compounded tirzepatide the same as Mounjaro?
Compounded tirzepatide contains the same active molecule as Mounjaro. The pharmacological mechanism — dual GIP and GLP-1 receptor activation — is identical. The differences are in the delivery device (vial and syringe vs pre-filled pen), inactive ingredients, manufacturing process, and price. Mounjaro is manufactured by Eli Lilly under strict FDA oversight, while compounded tirzepatide is prepared by licensed compounding pharmacies under FDA and state Board of Pharmacy regulations.
Can I get Mounjaro-level results with a compounded alternative?
Yes, because the active ingredient is the same. The SURMOUNT clinical trials showed tirzepatide producing 15 to 22.5 percent average weight loss depending on dose. These results reflect the drug's activity, not the manufacturer. Patients using compounded tirzepatide at equivalent doses and following proper protocols should expect comparable outcomes. Individual results vary based on dosing, adherence, lifestyle, and metabolic factors.
Are there non-tirzepatide alternatives to Mounjaro?
Yes. Semaglutide — available as brand-name Wegovy or Ozempic, or as compounded semaglutide — is a GLP-1 receptor agonist that produces significant weight loss (15 to 17 percent average). While tirzepatide's dual-action mechanism produced greater weight loss in head-to-head comparisons, semaglutide is still highly effective and may be slightly less expensive in compounded form. Some patients also tolerate one medication better than the other in terms of side effects.
How do I switch from Mounjaro to compounded tirzepatide?
Switching is simple. Contact a telehealth provider like Trimi, complete the health assessment with your current Mounjaro dose information, and the provider will prescribe the equivalent compounded tirzepatide dose. Since the active ingredient is identical, you continue your current dose at your next scheduled injection with the compounded version. There is no washout period or need to restart titration.
Is compounded tirzepatide safe?
Compounded tirzepatide from accredited compounding pharmacies is generally considered safe. The active ingredient carries the same safety profile as brand-name Mounjaro. The quality variable is the compounding pharmacy itself — which is why choosing a provider that partners with PCAB-accredited or FDA-registered 503A community sterile-compounding pharmacy is essential. These pharmacies conduct potency and sterility testing and operate under rigorous quality standards.
Do I need a prescription for Mounjaro alternatives?
Yes, all legitimate tirzepatide alternatives — whether brand-name or compounded — require a prescription from a licensed healthcare provider. Telehealth platforms like Trimi provide access to licensed providers who evaluate your medical history and prescribe compounded tirzepatide when clinically appropriate. Any source offering tirzepatide without a prescription should be avoided.
Sources & References
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication. Trimi provides compounded tirzepatide — readers should be aware of our perspective.